Introduction
Mealtime Insulin, challenges, and New Standard Management.
Objectives
Highlight the current challenges in mealtime insulin management
Help understand why ultra rapid acting lispro could be the new standard of Mealtime insulin management
Reinforce patient profiles suitable for ultra-rapid acting lispro
This Course For :
Physician
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )
Resident / Fellow
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )
Speaker
Dr. Christophe De Block, Belgium
Head of the Department of Endocrinology-Diabetology & Metabolism at Antwerp University Hospital Full Professor at the University of Antwerp
Dr. Hood Thabit, UK
Consultant Diabetologist
Senior lecturer at Manchester University Hospital Foundation Trust
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
03 May 2023 To 03 May 2023 -
07:00 PM To 08:00 PM 
Certificate Available 
Online Click Here
- 623
Add to Calendar
05/03/2023 07:00 PM
05/03/2023 08:00 PM
Asia/ Riyadh
Should Ultra Rapid Acting Analogs be the New Standard of Mealtime Insulin?
Should Ultra Rapid Acting Analogs be the New Standard of Mealtime Insulin?
https://medicalacademy.org/portal/event/view/1949
